ZYBT
Zhengye Biotechnology Holding Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.61
−1.23%Margins
Gross margin
20.5%
EBITDA margin
-36.5%
EBIT margin
-58.7%
Net margin
-60.0%
FCF margin
0.6%
-27.9%
Return on equity
-16.0%
Return on assets
-21.0%
Return on invested capital
0.27x
Asset turnover
$2.0M
Cash from operations
$0.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025